| 注册
首页|期刊导航|数字中医药(英文)|不同产地白芍与赤芍的氨基酸特征谱表征研究

不同产地白芍与赤芍的氨基酸特征谱表征研究

李莎莎 张怡萍 邓远辉 王倩 谢志茹 Ibarra-Estrada Emmanuel 肖雪

数字中医药(英文)2021,Vol.4Issue(2):120-129,10.
数字中医药(英文)2021,Vol.4Issue(2):120-129,10.DOI:10.1016/j.dcmed.2021.06.005

不同产地白芍与赤芍的氨基酸特征谱表征研究

Evaluation of Baishao (Paeoniae Radix Alba) and Chishao (Paeoniae Radix Rubra) from different origins based on characteristic spectra of amino acids

李莎莎 1张怡萍 1邓远辉 1王倩 1谢志茹 2Ibarra-Estrada Emmanuel 1肖雪2

作者信息

  • 1. 广州中医药大学第二临床医学院,广东 广州 510006,中国
  • 2. 广东药科大学中医药研究院,广东 广州 510006,中国
  • 折叠

摘要

Abstract

Objective To evaluate the difference between Baishao (Paeoniae Radix Alba, PRA) and Chishao (Paeoniae Radix Rubra, PRR) from different regions based on the characteristic spectra of amino acids (AAs). Methods Fingerprints of the 21 standard AAs were established using O-phthalaldehyde-9-fluorenylmethyl chloroformate (OPA-FMOC) pre-column derivation method. The AA components in PRA and PRR were characterized qualitatively and quantitatively, and different AAs were screened using pattern recognition technology. Results Twelve AAs were identified in both PRA and PRR. Meanwhile, aspartic acid, glutamic acid, arginine, alanine, and gamma-aminobutyric acid were screened as characteristic components, and their concentrations could effectively distinguish PRA from PRR. Conclusion The established characterization method, which is based on the characteristic spectra of AAs, is accurate, efficient, and sensitive and can effectively distinguish between PRA and PRR from different producing areas, thus providing a reference for the overall characterization and evaluation of Chinese medicinal materials.

关键词

OPA-FMOC柱前衍生法/氨基酸特征谱/白芍/赤芍/模式识别

Key words

O-phthalaldehyde-9-fluorenylmethyl chloroformate (OPA-FMOC) pre-column derivatization method/Amino acids characteristic spectra/Baishao (Paeoniae Radix Alba, PRA)/Chishao (Paeoniae Radix Rubra, PRR)/Pattern recognition

引用本文复制引用

李莎莎,张怡萍,邓远辉,王倩,谢志茹,Ibarra-Estrada Emmanuel,肖雪..不同产地白芍与赤芍的氨基酸特征谱表征研究[J].数字中医药(英文),2021,4(2):120-129,10.

基金项目

We thank for the funding support from the Guang-dong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases(No.2018B030322012). (No.2018B030322012)

数字中医药(英文)

2096-479X

访问量0
|
下载量0
段落导航相关论文